Skip to main content

Want a detailed portfolio tracker?

Aptorum Group Limited Ordinary Shares (APM) P/E (2018 - 2026)

Aptorum Group Limited Ordinary Shares (APM) P/E from Dec 31, 2018 to Jul 17, 2026. The TTM Aptorum Group Limited Ordinary Shares (APM) P/E is -3.78. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Aptorum Group Limited Ordinary Shares (APM)

YearP/EChange
2026-3.78-33.96%
2025-5.73+60.25%
2024-3.58+371.72%
2023-0.76-1.47%
2022-0.77-63.33%
2021-2.10-113.42%
202015.63-163.54%
2019-24.60-13.89%
2018-28.57N/A

Comparison Aptorum Group Limited Ordinary Shares (APM) P/E with competitors

Aptorum Group Limited Ordinary Shares (APM) P/E is -3.78.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.98%
FGENFibroGen Inc0.24-106.34%
CHRSCoherus Biosciences Inc0.85-122.42%
FBIOFortress Biotech Inc0.95-125.08%
ORMPOramed Pharmaceuticals Inc1.50-139.72%
AGENAgenus Inc3.01-179.53%
INVAInnoviva Inc3.15-183.35%
VXRTVaxart Inc3.55-193.81%
CRMDCorMedix Inc3.63-195.89%
CVACCureVac N.V.4.45-217.48%
GLPGGalapagos NV4.86-228.40%
SRPTSarepta Therapeutics Inc4.88-229.01%
ABEOAbeona Therapeutics Inc5.39-242.37%
ABUSArbutus Biopharma Corp5.60-247.87%
ZVRAZevra Therapeutics Inc5.89-255.58%
SPROSpero Therapeutics Inc6.23-264.59%
CGENCompugen Ltd6.31-266.85%
RIGLRigel Pharmaceuticals6.87-281.60%
SLXNSilexion Therapeutics Corp7.30-292.81%
OMEROmeros Corporation9.26-344.67%
AUPHAurinia Pharmaceuticals Inc9.58-353.29%
PLXProtalix BioTherapeutics Inc10.89-387.81%
ACADAcadia Pharmaceuticals Inc11.73-409.94%
TBPHTheravance Biopharma Inc12.26-424.04%
ADMAAdma Biologics Inc12.42-428.16%
HRMYHarmony Biosciences Holdings Inc13.82-465.21%
SABSSAB Biotherapeutics Inc14.14-473.56%
NAGENiagen Bioscience Inc14.82-491.58%
INCYIncyte Corp15.82-518.13%
REGNRegeneron Pharmaceuticals Inc15.86-519.03%
PBYIPuma Biotechnology Inc17.32-557.59%
CPRXCatalyst Pharmaceuticals Inc17.44-560.85%
EXELExelixis Inc17.54-563.46%
TGTXTG Therapeutics Inc18.97-601.20%
MDXGMimedx Group Inc20.55-643.12%
XOMAXOMA Royalty Corp22.87-704.50%
ARGXArgen X SE24.30-742.12%
CTMXCytomX Therapeutics Inc24.82-755.94%
XOMAOXOMA Royalty Corp25.34-769.78%
HALOHalozyme Therapeutics Inc25.62-777.15%
XOMAPXOMA Royalty Corp25.67-778.38%
VRTXVertex Pharmaceuticals Inc27.99-839.81%
RPRXRoyalty Pharma plc - Class A28.69-858.12%
SLNOSoleno Therapeutics Inc29.02-866.78%
ASNDAscendis Pharma A/S30.09-895.06%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1101.89%
BMRNBiomarin Pharmaceutical Inc42.21-1215.52%
KRYSKrystal Biotech Inc45.34-1298.28%
ONCBeiGene Ltd69.54-1937.73%
PHARPharming Group N.V.75.03-2082.69%
TECHBio-Techne Corp101.96-2794.44%
VCELVericel Corp109.92-3004.87%
ALNYAlnylam Pharmaceuticals Inc117.96-3217.44%
GMABGenmab140.29-3807.44%
TLXTelix Pharmaceuticals Ltd162.15-4385.18%
CORTCorcept Therapeutics Inc212.86-5725.15%